Defence Therapeutics: Developing Next Generation Biopharmaceutical Innovations
Defence Therapeutics is a publicly-traded biotechnology company working on engineering the next generation vaccines and ADC products using its proprietary platform.
Stocks to Invest in: Healthcare
Defence Therapeutics is a publicly-traded biotechnology company working on engineering the next generation vaccines and ADC products using its proprietary platform. The core of Defence Therapeutics platform is the ACCUM technology, which enables precision delivery of vaccine antigens or ADCs in their intact form to target cell.
Defence Therapeutics is a Canadian Biotech developing next generation biopharmaceutical innovations for various immuno-oncology (IO) and infectiousdiseases (ID) indications
For more information on Defence Therapeutics Inc. (CSE: DTC, OTC: DTCFF) please click the request investor info button.
Latest Articles
Hot Companies
You might also like
Volta Metals: Powering the Future with Ontario’s Critical Minerals
As global demand for critical minerals surges, Volta Metals is strategically positioned in Northwestern Ontario, exploring lithium and rare metals in proximity to infrastructure and clean energy sources.
.png)
.png)
